Outcomes of patients with Acute Myeloid Leukemia receiving venetoclax in combination with azacitidine: A single center retrospective study from Pakistan.
Our findings contribute to the growing evidence that venetoclax combined with azacitidine is an effective treatment option for elderly patients with AML who are not eligible for intensive treatment.
Authors
- Junaid Alam (ORCID: https://orcid.org/0000-0002-3952-5547)
- Akbar Shoukat Ali (ORCID: https://orcid.org/0000-0002-3654-6051)
- Lavita Kumari
- Usman Shaikh
Institutions
- Aga Khan University Hospital (PK)
Publication Details
- Journal
- PubMed
- Published
- 2025-01-01
- DOI
- https://doi.org/10.2478/jcas-2025-0001
- Primary Topic
- Acute Myeloid Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00